View Filing Data

Print Document View Excel Document

Document And Entity Information - shares	6 Months Ended
Document And Entity Information - shares	Jun. 30, 2017	Aug. 07, 2017
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2017
Document Fiscal Year Focus	2017
Document Fiscal Period Focus	Q2
Entity Registrant Name	FORM Holdings Corp.
Entity Central Index Key	0001410428
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Trading Symbol	FH
Entity Common Stock, Shares Outstanding		26,483,467

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2017	Dec. 31, 2016
Current assets
Cash and cash equivalents	$ 7,958	$ 17,910
Accounts receivable, net	2,216	404
Inventory	4,327	2,890
Other current assets	935	2,150
Assets held for disposal	467	1,507
Total current assets	15,903	24,861
Restricted cash	476	638
Property and equipment, net	14,377	16,284
Intangible assets, net	14,475	15,233
Goodwill	25,821	24,409
Other assets	1,330	1,382
Total assets	72,382	82,807
Current liabilities
Accounts payable, accrued expenses and other current liabilities	11,437	11,434
Deferred revenue	201	133
Liabilities held for disposal	97	206
Total current liabilities	11,735	11,773
Long-term liabilities
Debt	6,500	6,500
Derivative warrant liabilities	100	259
Other liabilities	794	106
Total liabilities	19,129	18,638
Commitments and contingencies (see Note 11)
Equity
Common stock, $0.01 par value per share; 150,000,000 shares authorized; 19,565,531 and 18,304,881 issued and outstanding as of June 30, 2017 and December 31, 2016, respectively	196	183
Additional paid-in capital	282,603	280,221
Accumulated deficit	(234,303)	(220,868)
Accumulated other comprehensive loss	(164)	(13)
Total equity attributable to the Company	48,336	59,528
Noncontrolling interests	4,917	4,641
Total equity	53,253	64,169
Total liabilities and equity	72,382	82,807
Series A Convertible Preferred Stock [Member]
Equity
Preferred stock	0	0
Series B Convertible Preferred Stock [Member]
Equity
Preferred stock	0	0
Series C Junior Preferred Stock [Member]
Equity
Preferred stock	0	0
Series D Convertible Preferred Stock [Member]
Equity
Preferred stock	$ 4	$ 5

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)	Jun. 30, 2017	Dec. 31, 2016
Common stock, par value	$ 0.01	$ 0.01
Common stock, authorized	150,000,000	150,000,000
Common stock, issued	19,565,531	18,304,881
Common stock, outstanding	19,565,531	18,304,881
Series A Convertible Preferred Stock [Member]
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, authorized	500,000	500,000
Preferred stock, issued	6,968	6,968
Preferred stock, outstanding	0	0
Series B Convertible Preferred Stock [Member]
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, authorized	5,000,000	5,000,000
Preferred stock, issued	1,666,667	1,666,667
Preferred stock, outstanding	0	0
Series C Junior Preferred Stock [Member]
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, authorized	300,000	300,000
Preferred stock, issued	0	0
Preferred stock, outstanding	0	0
Series D Convertible Preferred Stock [Member]
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, authorized	500,000	500,000
Preferred stock, issued	475,208	491,427
Preferred stock, outstanding	429,948	491,427
Preferred Stock, Liquidation Preference, Value	$ 20,638	$ 23,588

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands

3 Months Ended

6 Months Ended

Jun. 30, 2017

Jun. 30, 2016

Jun. 30, 2017

Jun. 30, 2016

Revenue

Wellness

$ 12,927

$ 0

$ 23,911

$ 0

Technology

3,450

2,450

6,941

3,727

Intellectual property

8,900

100

9,650

Total revenue

16,377

11,350

30,952

13,377

Cost of sales

Wellness

10,401

19,236

Technology

2,690

2,180

5,618

3,304

Intellectual property

^[1]

118

4,243

217

4,963

Total cost of sales

13,209

6,423

25,071

8,267

Depreciation, amortization and impairment

3,094

12,329

4,955

13,159

General and administrative

^[1]

5,204

2,316

11,539

4,495

Total operating expenses

21,507

21,068

41,565

25,921

Operating loss from continuing operations

(5,130)

(9,718)

(10,613)

(12,544)

Non-operating income (expense), net

(50)

181

518

Interest expense

(178)

(272)

(367)

(748)

Extinguishment of debt

(210)

Loss from continuing operations before income taxes

(5,358)

(9,809)

(10,919)

(12,984)

Income tax expense

(227)

Consolidated net loss from continuing operations

(5,358)

(9,809)

(11,146)

(12,984)

Loss from discontinued operations before income taxes

(1,552)

(998)

(2,113)

(1,778)

Income tax expense

Net loss from discontinued operations

(1,552)

(998)

(2,113)

(1,778)

Consolidated net loss

(6,910)

(10,807)

(13,259)

(14,762)

Net income attributable to noncontrolling interests

(100)

(176)

Net loss attributable to the Company

(7,010)

(10,807)

(13,435)

(14,762)

Other comprehensive loss: foreign currency translation

(151)

Comprehensive loss

$ (7,017)

$ (10,807)

$ (13,410)

$ (14,762)

Basic and diluted net loss per share

Loss per share from continuing operations (in dollars per share)

$ (0.28)

$ (0.65)

$ (0.59)

$ (0.89)

Loss per share from discontinued operations (in dollars per share)

(0.08)

(0.07)

(0.11)

(0.12)

Total basic and diluted net loss per share (in dollars per share)

$ (0.36)

$ (0.72)

$ (0.70)

$ (1.01)

Weighted-average number of shares outstanding during the period:

Basic (in shares)

19,310,994

14,993,686

19,178,769

14,576,183

Diluted (in shares)

19,310,994

14,993,686

19,178,769

14,576,183

Includes stock-based compensation expense, as follows:

Total stock-based compensation expense

$ 732

$ 499

$ 1,473

$ 962

General and Administrative [Member]

Includes stock-based compensation expense, as follows:

Total stock-based compensation expense

732

435

1,473

830

Intellectual Property Cost [Member]

Includes stock-based compensation expense, as follows:

Total stock-based compensation expense

132

Discontinued Operations [Member]

Cost of sales

Net loss from discontinued operations

(1,552)

(998)

(2,113)

(1,778)

Other comprehensive loss: foreign currency translation

Comprehensive loss

(1,552)

(998)

(2,113)

(1,778)

Continuing Operations [Member]

Cost of sales

Consolidated net loss from continuing operations

(5,358)

(9,809)

(11,146)

(12,984)

Other comprehensive loss: foreign currency translation

(107)

(151)

Comprehensive loss

$ (5,465)

$ (9,809)

$ (11,297)

$ (12,984)

[1]	Includes stock-based compensation expense, as follows: Intellectual property, General and administrative.

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($) $ in Thousands	Total	Common stock [Member]	Preferred stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Accumulated Other Comprehensive Loss [Member]	Total FORM Equity [Member]	Non-controlling Interests [Member]
Balance at Dec. 31, 2015	$ 40,516	$ 132	$ 0	$ 237,246	$ (196,862)	$ 0	$ 40,516	$ 0
Issuance of common stock for repayment of convertible debt and related interest	2,996	18	0	2,978	0	0	2,996	0
Stock-based compensation	962	0	0	962	0	0	962	0
Net loss for the period	(14,762)	0	0	0	(14,762)	0	(14,762)	0
Balance at Jun. 30, 2016	29,712	150	0	241,186	(211,624)	0	29,712	0
Balance at Dec. 31, 2016	64,169	183	5	280,221	(220,868)	(13)	59,528	4,641
Issuance of common stock for services	20	0	0	20	0	0	20	0
Shares of common stock issued for the acquisition of Excalibur	1,809	9	0	1,800	0	0	1,809	0
Decrease in shares of preferred stock issued to XpresSpa sellers	(908)	0	0	(908)	0	0	(908)	0
Conversion of preferred stock to common stock	0	4	(1)	(3)	0	0	0	0
Stock-based compensation	1,473	0	0	1,473	0	0	1,473	0
Net loss for the period	(13,259)	0	0	0	(13,435)	0	(13,435)	176
Foreign currency translation	(151)	0	0	0	0	(151)	(151)	0
Contributions from noncontrolling interests	100	0	0	0	0	0	0	100
Balance at Jun. 30, 2017	$ 53,253	$ 196	$ 4	$ 282,603	$ (234,303)	$ (164)	$ 48,336	$ 4,917

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016
Cash flows from operating activities
Consolidated net loss	$ (13,259)	$ (14,762)
Items not affecting cash flows
Depreciation and amortization	4,955	1,222
Impairment of intangible assets	0	11,937
Amortization of debt discount and debt issuance costs	0	660
Stock-based compensation	1,473	962
Amendment to warrants as part of debt modification	0	(281)
Extinguishment of debt	0	356
Issuance of shares of common stock for services	20	0
Change in fair value of derivative warrant liabilities and conversion feature	(159)	(87)
Exchange rate loss (gain), net	0	(75)
Changes in current assets and liabilities net of effects of acquisition
Increase in accounts receivable	(1,277)	(139)
Increase in inventory	(1,386)	(32)
Decrease in other current assets and other assets	1,473	443
Increase (decrease) in accounts payable, accrued expenses and other current liabilities	(557)	375
Increase (decrease) in deferred revenue	(52)	146
Decrease in other liabilities	(15)	(246)
Net cash provided by (used in) operating activities - continuing operations	(8,784)	479
Net cash provided by operating activities - discontinued operations	931	219
Net cash provided by (used in) operating activities	(7,853)	698
Cash flows from investing activities
Cash acquired as part of acquisition	26	0
Acquisition of property and equipment	(1,565)	(151)
Acquisition of software	(148)	0
Decrease in deposits	0	2,001
Net cash provided by (used in) investing activities	(1,687)	1,850
Cash flows from financing activities
Repayment of line of credit	(361)	0
Net contributions from noncontrolling interests	100	0
Debt issuance costs	0	(50)
Net cash used in financing activities	(261)	(50)
Effect of exchange rate changes on cash and cash equivalents	(151)	0
Increase (decrease) in cash and cash equivalents	(9,952)	2,498
Cash and cash equivalents at beginning of period	17,910	24,951
Cash and cash equivalents at end of period	7,958	27,449
Cash paid during the period for
Interest	430	40
Noncash investing and financing transactions
Issuance of common stock to repay debt and interest	$ 0	$ 2,996

General

6 Months Ended

Jun. 30, 2017

General [Abstract]

General

Note 1. General

FORM Holdings Corp. (“FORM” or the “Company”) has three operating segments: wellness, technology and intellectual property.

The Company’s wellness operating segment consists of XpresSpa, which is a leading airport retailer of spa services. XpresSpa is a well-recognized airport spa brand with 52 locations, including 48 domestic and 4 international, as of June 30, 2017. XpresSpa offers travelers premium spa services, including massage, nail and hair as well as spa and travel products. The Company acquired XpresSpa in the fourth quarter of 2016.

The Company’s technology operating segment consists of Group Mobile as well as an 11% equity interest in InfoMedia Services Limited (“InfoMedia”). Group Mobile offers rugged hardware and software solutions, including laptops, tablets, and mobile printers, as well as installation and deployment services. The Company acquired Group Mobile in the fourth quarter of 2015 and Excalibur Integrated Systems Inc. (“Excalibur”), which was merged with Group Mobile, in the first quarter of 2017. The Company’s equity interest in InfoMedia increased from 8.25% to 11% in the first quarter of 2017 due to a realignment of ownership interests.

As further detailed in Note 10 “Discontinued Operations and Assets and Liabilities Held for Disposal,” during June 2017, the Company concluded that the requirement to report the results of FLI Charge as discontinued operations was triggered.

The Company is currently evaluating strategic alternatives with respect to Group Mobile in an attempt to enhance stockholder value. These strategic alternatives may include a possible sale, merger, spin-off or other separation of Group Mobile or other forms of business combinations or strategic transactions. The Company is seeking to enter into one or more strategic transactions involving Group Mobile in the first quarter of 2018.

The Company’s intellectual property operating segment is engaged in the monetization of patents related to content and ad delivery, remote monitoring and mobile technologies.

Accounting and Reporting Policies

6 Months Ended

Jun. 30, 2017

Accounting Policies [Abstract]

Accounting and Reporting Policies

Note 2. Accounting and Reporting Policies

(a) Basis of presentation and principles of consolidation

The accompanying interim condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) for interim financial information and the instructions to Rule 10-01 of Regulation S-X, and should be read in conjunction with the Company's Annual Report on Form 10-K for the year ended December 31, 2016. All adjustments that, in the opinion of management, are necessary for a fair presentation for the periods presented have been reflected by the Company. Such adjustments are of a normal, recurring nature. The results of operations for the three and six-month periods ended June 30, 2017 are not necessarily indicative of the results that may be expected for the entire fiscal year or for any other interim period. All significant intercompany balances and transactions have been eliminated in consolidation.

(b) Use of estimates

The preparation of the accompanying condensed consolidated financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses for the periods presented. Actual results may differ from such estimates. Significant items subject to such estimates and assumptions include the Company’s intangible assets, the useful lives of the Company’s intangible assets, the valuation of the Company’s derivative warrants, the valuation of stock-based compensation, deferred tax assets and liabilities, income tax uncertainties, and other contingencies.

(c) Revenue recognition

The Company recognizes revenue for the wellness operating segment from the sale of XpresSpa products and services at the point of sale, net of discounts and applicable sales taxes. Revenues from the XpresSpa wholesale and e-commerce businesses are recorded at the time goods are shipped. The Company excludes all sales taxes assessed to its customers. Sales taxes assessed on revenues are included in accounts payable, accrued expenses and other current liabilities in the condensed consolidated balance sheets until remitted to the state agencies.

The Company records revenue from product sales in the technology operating segment when title and risk of loss are passed to the customer, there is persuasive evidence of an arrangement for sale, delivery has occurred, the sales price is fixed or determinable, and collectability is reasonably assured. The Company’s shipping terms typically specify F.O.B. destination, at which time title and risk of loss have passed to the customer. At the time of sale of hardware products, the Company records an estimate for sales returns and allowances based on historical experience. Hardware products sold by the Company are warranted by the vendor.

The Company has drop-shipment arrangements with many of its hardware vendors and suppliers to deliver products directly to customers. Revenue for drop-shipment arrangements is recorded on a gross basis upon delivery to the customer with contract terms that typically specify F.O.B. destination. Revenue is recognized on a gross basis, as the Company is the principal in the transaction, as the primary obligor in the arrangement, assumes the inventory risk if the product is returned by the customer, sets the price of the product to the customer, assumes credit risk for the amounts invoiced, and works closely with the customers to determine their hardware specifications.

Freight billed to customers is recognized as net product revenue and the related freight costs as a cost of sales.

On certain occasions, the Company’s technology operating segment will enter into a bill and hold arrangement with a customer. When this occurs, the Company makes a determination as to when it will be the proper time to recognize revenue. In doing so, the Company takes the following into consideration:

•

whether the risks of ownership have passed to the customer;

•

the customer must have made a fixed commitment to purchase the goods;

•

the customer must request and have a substantial business purpose for ordering on a bill and hold basis;

•

there must be a fixed schedule for delivery that is reasonable and consistent with the customer’s business purpose;

•

the Company cannot retain any specific performance obligations that would make the earnings process incomplete;

•

the goods must be segregated from remaining inventory (i.e., they cannot be used to fill orders for others); and

•

the goods must be complete and ready for shipment.

For multiple-element arrangements in the Company’s technology operating segment that include hardware products, services and maintenance, the Company allocates revenue to all deliverables based on their relative selling prices. In such circumstances, the Company uses a hierarchy to determine the selling price to be used for allocating revenue to deliverables: (i) vendor-specific objective evidence of fair value (“VSOE”), (ii) third-party evidence of selling price (“TPE”) and (iii) best estimate of selling price (“ESP”). VSOE generally exists only when the Company sells the deliverable separately and is the price actually charged by the Company for that deliverable. ESPs reflect the Company’s best estimates of what the selling prices of elements would be if they were sold regularly on a stand-alone basis. The Company allocates revenue to all deliverables based on the VSOE of each element, and if VSOE does not exist revenue is recognized when elements lacking VSOE are delivered.

Revenue from patent licensing is recognized if collectability is reasonably assured, persuasive evidence of an arrangement exists, the sales price is fixed or determinable and delivery of the service has been rendered. Currently, revenue arrangements related to intellectual property provide for the payment of contractually determined fees and other consideration for the grant of certain intellectual property rights related to the Company’s patents. These rights typically include some combination of the following: (i) the grant of a non-exclusive, retroactive and future license to manufacture and/or sell products covered by patents, (ii) the release of the licensee from certain claims, and (iii) the dismissal of any pending litigation. The intellectual property rights granted typically extend until the expiration of the related patents. Pursuant to the terms of these agreements, the Company has no further obligation with respect to the grant of the non-exclusive retroactive and future licenses, covenants-not-to-sue, releases, and other deliverables, including no express or implied obligation on the Company’s part to maintain or upgrade the related technology, or provide future support or services. Generally, the agreements provide for the grant of the licenses, covenants-not-to-sue, releases, and other significant deliverables upon execution of the agreement, or upon receipt of the upfront payment. As such, the earnings process is complete and revenue is recognized upon the execution of the agreement, upon receipt of the upfront fee, and when all other revenue recognition criteria have been met.

(d) Cost of sales

Cost of sales for the Company’s wellness operating segment consists of store-level costs. Store-level costs include all costs that are directly attributable to the store operations and include:

•

payroll and related benefits for store operations and store-level management;

•

rent, percentage rent and occupancy costs;

•

the cost of merchandise;

•

freight, shipping and handling costs;

•

production costs;

•

inventory shortage and valuation adjustments, including purchase price allocation increase in fair values which was recorded as part of acquisition; and

•

costs associated with sourcing operations.

Cost of sales for the Company’s technology operating segment includes costs to acquire or manufacture goods for inventory.

Cost of sales for the Company’s intellectual property operating segment mainly includes expenses incurred in connection with the Company’s patent licensing and enforcement activities, patent-related legal expenses paid to external patent counsel (including contingent legal fees), licensing and enforcement related research, consulting and other expenses paid to third parties, as well as related internal payroll expenses.

(e) Recently adopted accounting pronouncements

ASU No. 2017-01, Business Combinations (Topic 805): Clarifying the Definition of a Business

In January 2017, the FASB issued Accounting Standards Update No. 2017-01 (“ASU 2017-01”) “Business Combinations (Topic 805): Clarifying the Definition of a Business.” ASU 2017-01 provides guidance to evaluate whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. If substantially all of the fair value of the gross assets acquired (or disposed of) is concentrated in a single asset or a group of similar assets, the assets acquired (or disposed of) are not considered a business. The Company adopted ASU 2017-01 as of January 1, 2017 on a prospective basis.

(f) Recent issued accounting pronouncements not yet adopted

ASU No. 2017-04, Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment

In January 2017, the FASB issued Accounting Standards Update No. 2017-04 (“ASU 2017-04”) “Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment.” ASU 2017-04 eliminates step two of the goodwill impairment test and specifies that goodwill impairment should be measured by comparing the fair value of a reporting unit with its carrying amount. Additionally, the amount of goodwill allocated to each reporting unit with a zero or negative carrying amount of net assets should be disclosed. ASU 2017-04 is effective for annual or interim goodwill impairment tests performed in fiscal years beginning after December 15, 2019; early adoption is permitted. The Company currently anticipates that the adoption of ASU 2017-04 will not have a material impact on its consolidated financial statements.

ASU No. 2017-09, Stock Compensation (Topic 718): Scope of Modification Accounting

In May 2017, the FASB issued Accounting Standards Update No. 2017-09 (“ASU 2017-09”) “Stock Compensation (Topic 718): Scope of Modification Accounting.” ASU 2017-09 provides guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting in Topic 718. The current disclosure requirements in Topic 718 apply regardless of whether an entity is required to apply modification accounting under the amendments in this update. ASU 2017-09 is effective for annual periods, and interim periods within those annual periods, beginning after December 15, 2017; early adoption is permitted. The Company is currently in the process of evaluating the potential impact of the adoption on its consolidated financial statements.

(g) Reclassification

Certain balances have been reclassified to conform to presentation requirements, including presentation of discontinued operations and assets and liabilities held for disposal with respect to the Company’s FLI Charge business (refer to Note 10), as well as consistent presentation of cost of sales and general and administrative expenses to align presentation for operating segments.

Net Loss per Share of Common Stock

6 Months Ended

Jun. 30, 2017

Earnings Per Share, Basic and Diluted [Abstract]

Net Loss per Common Share

Note 3. Net Loss per Share of Common Stock

Basic net loss per share is computed by dividing the net loss for the period by the weighted-average number of shares of common stock outstanding during the period. Diluted net loss per share is computed by dividing the net loss for the period by the weighted-average number of shares of common stock plus dilutive potential common stock considered outstanding during the period. However, as the Company generated a net loss in all periods presented, some potentially dilutive securities, including certain warrants and stock options, were not reflected in diluted net loss per share because the impact of such instruments was anti-dilutive.

The table below presents the computation of basic and diluted net loss per share of common stock:

	Three months ended June 30,				Six months ended June 30,
	2017		2016		2017		2016
Basic numerator:
Net loss from continuing operations attributable to shares of common stock	$	(5,458)	$	(9,809)	$	(11,322)	$	(12,984)
Net loss from discontinued operations attributable to shares of common stock		(1,552)		(998)		(2,113)		(1,778)
Net loss attributable to shares of common stock	$	(7,010)	$	(10,807)	$	(13,435)	$	(14,762)
Basic denominator:
Basic shares of common stock outstanding		19,310,994		14,993,686		19,178,769		14,576,183
Basic loss per share of common stock from continuing operations	$	(0.28)	$	(0.65)	$	(0.59)	$	(0.89)
Basic loss per share of common stock from discontinued operations		(0.08)		(0.07)		(0.11)		(0.12)
Basic net loss per share of common stock	$	(0.36)	$	(0.72)	$	(0.70)	$	(1.01)

Diluted numerator:
Net loss from continuing operations attributable to shares of common stock	$	(5,458)	$	(9,809)	$	(11,322)	$	(12,984)
Net loss from discontinued operations attributable to shares of common stock		(1,552)		(998)		(2,113)		(1,778)
Net loss attributable to shares of common stock	$	(7,010)	$	(10,807)	$	(13,435)	$	(14,762)
Diluted denominator:
Diluted shares of common stock outstanding		19,310,994		14,993,686		19,178,769		14,576,183
Diluted loss per share of common stock from continuing operations	$	(0.28)	$	(0.65)	$	(0.59)	$	(0.89)
Diluted loss per share of common stock from discontinued operations		(0.08)		(0.07)		(0.11)		(0.12)
Diluted net loss per share of common stock	$	(0.36)	$	(0.72)	$	(0.70)	$	(1.01)

Net loss per share data presented excludes from the calculation of diluted net loss the following potentially dilutive securities, as they had an anti-dilutive impact:
Both vested and unvested options to purchase an equal number of shares of common stock of the Company		5,135,399		1,492,434		5,135,399		1,492,434
Unvested restricted stock units (“RSUs”) to issue an equal number of shares of common stock of the Company		400,942		7,808		400,942		7,808
Warrants to purchase an equal number of shares of common stock of the Company		3,430,877		1,006,679		3,430,877		1,006,679
Preferred stock on an as converted basis		3,439,587		—		3,620,626		—
Conversion feature of senior secured notes		—		—		—		159,462
Total number of potentially dilutive instruments, excluded from the calculation of net loss per share		12,406,805		2,506,921		12,587,844		2,666,383

Business Combinations

6 Months Ended

Jun. 30, 2017

Business Combinations [Abstract]

Business Combinations

Note 4. Business Combinations

XpresSpa

During the three months ended June 30, 2017, the Company learned new information about legal and other professional costs which existed as of the acquisition date of XpresSpa. As a result, the Company and the sellers of XpresSpa (the “XpresSpa Sellers”) agreed to reduce the total amount of Series D Convertible Preferred Stock (“FORM Preferred Stock”), which was previously issued to the XpresSpa Sellers in conjunction with the acquisition of XpresSpa. The Company reduced the number of the FORM Preferred Stock by 16,219 shares and estimated that the fair value of the reduction of the consideration was $908, which was recorded as a reduction of preferred equity and goodwill.

Additionally, during the three months ended June 30, 2017, certain XpresSpa Sellers converted 45,260 shares of their FORM Preferred Stock into 362,077 shares of the Company’s common stock, par value $0.01 per share.

As a result of these events, the total number of shares of FORM Preferred Stock was reduced from 491,427 as of December 31, 2016 to 429,948 shares as of June 30, 2017 and the face value (and liquidation preference) was reduced from $23,588 to $20,638.

Group Mobile

On February 2, 2017, the Company acquired Excalibur, which is an end-to-end solutions provider of mobile hardware devices, wireless network security, data networking, telephony and mobile application development and software solutions. Following the acquisition, Excalibur was merged with Group Mobile within the Company’s technology operating segment.

In consideration for the acquisition, the Company issued 888,573 unregistered shares of the Company’s common stock, par value $0.01 per share, to the former stockholders of Excalibur (the “Excalibur Sellers”). In addition, the Excalibur Sellers will, in the three years following the closing of this transaction, also receive $500 for each $2,000 of gross profit generated by a specified list of Excalibur accounts annually, until such cumulative gross profit reaches $6,000, and an additional $500 when such cumulative profit reaches $10,000, such amounts are payable in either cash or the Company’s common stock, at the election of the Company.

The fair value of the total purchase price is $2,125 and includes a fair value of contingent consideration of $316 and fair value of unregistered shares of common stock issued of $1,809.

Assets acquired and liabilities assumed were recorded at their fair values as of the acquisition date. The purchase price for the acquisition was allocated to the net tangible and intangible assets based on their fair values as of the acquisition date. The excess of the purchase price over the net tangible assets and intangible assets was recorded as goodwill. The table below presents preliminary allocation of the purchase price:

	Fair Value
Assets
Current assets (including cash of $26)	$	628
Deferred tax assets		29
Property and equipment		21
Intangible assets		556
Goodwill		2,320
Total assets		3,554

Liabilities
Accounts payable and accrued expenses		1,214
Deferred tax liabilities		215
Total liabilities		1,429
Net assets, fair value	$	2,125

The allocation of the purchase price was based upon a preliminary valuation performed using the Company's estimates and assumptions, which are subject to change within the measurement period (up to one year from the acquisition date).

Segment Information

6 Months Ended

Jun. 30, 2017

Segment Reporting [Abstract]

Segment Information

Note 5. Segment Information

The Company’s operating segments are defined as components of an enterprise about which separate financial information is available that is regularly evaluated by the enterprise’s chief operating decision maker (“CODM”) in deciding how to allocate resources and in assessing performance. The Company concluded that it conducts its business through three operating segments, which are also its reportable segments:

•

wellness (XpresSpa);

•

technology (Group Mobile); and

•

intellectual property

Segment operating results reflect losses before corporate and unallocated shared expenses, interest expense and income taxes. Corporate and unallocated shared expenses principally consist of costs for corporate functions, rent for office space, stock-based compensation, executive management and certain unallocated administrative support functions.

	Three months ended June 30,				Six months ended June 30,
	2017		2016		2017		2016
Revenue
Wellness	$	12,927	$	—	$	23,911	$	—
Technology		3,450		2,450		6,941		3,727
Intellectual property		—		8,900		100		9,650
Total revenue		16,377		11,350		30,952		13,377

Cost of sales
Wellness		10,401		—		19,236		—
Technology		2,690		2,180		5,618		3,304
Intellectual property		118		4,243		217		4,963
Total cost of sales		13,209		6,423		25,071		8,267

Segment operating loss
Wellness		(1,992)		—		(4,363)		—
Technology		(742)		(327)		(1,656)		(648)
Intellectual property		(126)		(7,577)		(131)		(8,280)
Corporate		(2,270)		(1,814)		(4,463)		(3,616)
Total segment operating loss		(5,130)		(9,718)		(10,613)		(12,544)
Corporate non-operating expense, net		(228)		(91)		(306)		(440)
Loss from continuing operations before income taxes	$	(5,358)	$	(9,809)	$	(10,919)	$	(12,984)

	June 30, 2017		December 31, 2016
Assets
Wellness	$	53,137	$	57,527
Technology		4,602		8,634
Intellectual property		825		940
Corporate		13,818		15,706
Total assets	$	72,382	$	82,807

General and administrative costs are allocated among the operating segments and non-operating corporate segment. The non-operating corporate segment does not have any revenue, but does incur expenses such as compensation expenses, rent and infrastructure costs. The non-operating corporate segment’s assets are mainly comprised of cash.

The Company currently operates in two geographical regions: United States and all other countries. The following table represents the geographical revenue, regional operating loss, and total asset information as of and for the three and six months ended June 30, 2017 and 2016. There were no concentrations of geographical revenue, regional operating loss or total assets related to any single foreign country that were material to the Company’s condensed consolidated financial statements.

	Three months ended June 30,				Six months ended June 30,
	2017		2016		2017		2016
Revenue
United States	$	15,115	$	11,350	$	28,574	$	13,377
All other countries		1,262		—		2,378		—
Total revenue		16,377		11,350		30,952		13,377

Cost of sales
United States		12,384		6,423		23,569		8,267
All other countries		825		—		1,502		—
Total cost of sales		13,209		6,423		25,071		8,267

Segment operating income (loss)
United States		(5,636)		(9,713)		(11,309)		(12,541)
All other countries		506		(5)		696		(3)
Total segment operating income (loss)		(5,130)		(9,718)		(10,613)		(12,544)
Corporate non-operating expense, net		(228)		(91)		(306)		(440)
Loss from continuing operations before income taxes	$	(5,358)	$	(9,809)	$	(10,919)	$	(12,984)

	June 30, 2017		December 31, 2016
Assets
United States	$	70,380	$	80,053
All other countries		2,002		2,754
Total assets	$	72,382	$	82,807

Fair Value Measurements

6 Months Ended

Jun. 30, 2017

Fair Value Disclosures [Abstract]

Fair Value Measurements

Note 6. Fair Value Measurements

Derivative Warrant Liabilities

The following table presents the placement in the fair value hierarchy of derivate warrant liabilities measured at fair value on a recurring basis as of June 30, 2017 and December 31, 2016:

			Fair value measurement at reporting date using
			Quoted prices in
			active markets		Significant other		Significant
			for identical		observable		unobservable
	Balance		assets (Level 1)		inputs (Level 2)		inputs (Level 3)
June 30, 2017:
May 2015 Warrants	$	100	$	—	$	—	$	100

December 31, 2016:
May 2015 Warrants	$	259	$	—	$	—	$	259

The Company measures its derivative warrant liabilities at fair value. The May 2015 Warrants were classified within Level 3 because they were valued using the Black-Scholes-Merton model, which utilizes significant inputs that are unobservable in the market. These derivative warrant liabilities were initially measured at fair value and are marked to market at each balance sheet date.

In addition to the above, the Company’s financial instruments as of June 30, 2017 and December 31, 2016 consisted of cash and cash equivalents, receivables, accounts payable and Debt. The carrying amounts of all the aforementioned financial instruments approximate fair value because of the short-term maturities of these instruments.

The following table summarizes the changes in the Company’s derivative warrant liabilities measured at fair value using significant unobservable inputs (Level 3) during the three- and six-month periods ended June 30, 2017:

	May 2015
	Warrants
December 31, 2016	$	259
Decrease in fair value of the derivative warrant liabilities		(159)
June 30, 2017	$	100

Valuation processes for Level 3 Fair Value Measurements

Fair value measurement of the derivative warrant liabilities falls within Level 3 of the fair value hierarchy. The fair value measurements are evaluated by management to ensure that changes are consistent with expectations of management based upon the sensitivity and nature of the inputs.

June 30, 2017:

Description	Valuation technique	Unobservable inputs	Range
May 2015 Warrants	Black-Scholes-Merton	Volatility		42.12	%
		Risk free interest rate		1.51	%
		Expected term, in years		2.84
		Dividend yield		0.00	%

December 31, 2016:

Description	Valuation technique	Unobservable inputs	Range
May 2015 Warrants	Black-Scholes-Merton	Volatility		45.15	%
		Risk-free interest rate		1.57	%
		Expected term, in years		3.34
		Dividend yield		0.00	%

Sensitivity of Level 3 measurements to changes in significant unobservable inputs

The inputs to estimate the fair value of the Company’s derivative warrant liabilities were the current market price of the Company’s common stock, the exercise price of the derivative warrant liabilities, their remaining expected term, the volatility of the Company’s common stock price and the risk-free interest rate over the expected term. Significant changes in any of those inputs in isolation can result in a significant change in the fair value measurement.

Generally, an increase in the market price of the Company’s shares of common stock, an increase in the volatility of the Company’s shares of common stock, and an increase in the remaining term of the derivative warrant liabilities would each result in a directionally similar change in the estimated fair value of the Company’s derivative warrant liabilities. Such changes would increase the associated liability while decreases in these assumptions would decrease the associated liability. An increase in the risk-free interest rate or a decrease in the differential between the derivative warrant liabilities’ exercise price and the market price of the Company’s shares of common stock would result in a decrease in the estimated fair value measurement and thus a decrease in the associated liability. The Company has not, and does not plan to, declare dividends on its common stock and, as such, there is no change in the estimated fair value of the derivative warrant liabilities due to the dividend assumption.

Other Fair Value Measurements

The following table presents the placement in the fair value hierarchy of shares of the contingent consideration assumed by the Company following the acquisition of Excalibur, which is measured at fair value on a recurring basis, and the decrease in shares of FORM Preferred Stock issued to the XpresSpa Sellers, which was measured at fair value on a non-recurring basis as of April 4, 2017 (the “Valuation Date”):

			Fair value measurement at reporting date using
			Quoted prices in
			active markets		Significant other		Significant
			for identical		observable		unobservable
	Balance		assets (Level 1)		inputs (Level 2)		inputs (Level 3)
June 30, 2017:
Contingent consideration	$	316	$	—	$	—	$	316
FORM Preferred Stock	$	908	$	—	$	—	$	908

The purchase value of the contingent consideration assumed by the Company following the acquisition of Excalibur and the fair value of the decrease in shares of FORM Preferred Stock issued to the XpresSpa Sellers were determined using the Monte-Carlo simulation and, as such, were classified as Level 3 of the fair value hierarchy. The fair value measurements are evaluated by management to ensure that changes are consistent with expectations of management based upon the sensitivity and nature of the inputs.

Valuation processes for Level 3 Fair Value Measurements

To estimate the fair value of the decrease in shares of FORM Preferred Stock, the Monte-Carlo simulation was performed using the following variables:

Description	Valuation technique	Variables	Range
FORM Preferred Stock	Monte-Carlo	Share price as of the Valuation Date	$	1.95
		Volatility		46.0	%
		Risk free interest rate		2.22	%

Additionally, the Monte-Carlo simulation used the value of the underlying equity value issued to XpresSpa Sellers on the date of the XpresSpa acquisition, December 23, 2016, which is comprised of the aggregation of the fair value of the shares of the Company’s common stock, shares of FORM Preferred Stock and warrants.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

Stock-based Compensation

6 Months Ended

Jun. 30, 2017

Share-based Compensation [Abstract]

Stock-based Compensation

Note 7. Stock-based Compensation

As of June 30, 2017, 1,258,603 shares of the Company’s common stock were available for future grants under the Company’s 2012 Employee, Director and Consultant Equity Incentive Plan. Total stock-based compensation expense for the six-month periods ended June 30, 2017 and 2016 was $1,473 and $962, respectively. Total stock-based compensation expense for the three-month periods ended June 30, 2017 and 2016 was $732 and $499, respectively.

The following table illustrates the options granted during the six-month period ended June 30, 2017.

Assumptions used in

Black-

No. of

Exercise

Fair value at

Scholes option pricing

Title

Grant date

options

price

grant date

Vesting terms

model

Directors, management, and

January 2017

1,545,000

$2.12 – $2.15

$0.89 – $0.96

Over 1 year for directors; Over 3 years

Volatility: 44.27% – 44.90%

employees

for management and employees

Risk free interest rate: 1.95% – 2.16%

Expected term, in years: 5.29 – 5.79

Dividend yield: 0.00%

The following table illustrates the RSUs granted during the six-month period June 30, 2017.

Title

Grant date

No. of RSUs

Fair value at grant date

Vesting term

Management and employees

January 2017

400,942

2.12

Over 1 year period, vesting on 1 year anniversary of grant date

The activity related to stock options and RSUs during the six-month period ended June 30, 2017 consisted of the following:

	RSUs				Options
			Weighted				Weighted				Weighted
			average				average				average
	No. of		grant date		No. of		exercise		Exercise		grant date
	RSUs		fair value		options		price		price range		fair value
Outstanding as of January 1, 2017		—		—		3,679,101	$	7.60	$	1.55 – 55.00	$	5.41
Granted		400,942	$	2.12		1,545,000	$	2.12	$	2.12 – 2.15	$	0.93
Vested/Exercised		—		—		—		—		—		—
Forfeited		—		—		(72,334)	$	24.80	$	1.55 – 37.20	$	16.81
Expired		—		—		(16,368)	$	43.66	$	9.94 – 55.00	$	22.02
Outstanding as of June 30, 2017		400,942	$	2.12		5,135,399	$	5.60	$	1.55 – 41.00	$	3.85
Exercisable as of June 30, 2017		—				2,459,982	$	9.72	$	1.55 – 41.00

On January 20, 2017, the Company entered into amended employment agreements with its named executive officers. Under the terms of certain of these agreements, certain of these officers are entitled to a percentage of the amount equal to the total amount of cash and the fair market value of all noncash consideration paid or payable to the Company or its stockholders in connection with an initial public offering or a change of control of certain subsidiaries of the Company. The amended employment agreements also allow for the granting of equity awards to certain officers in connection with an initial public offering of certain subsidiaries of the Company.

The Company did not recognize tax benefits related to its stock-based compensation as there is a full valuation allowance recorded.

Income Taxes

6 Months Ended

Jun. 30, 2017

Income Tax Disclosure [Abstract]

Income Taxes

Note 8. Income Taxes

The Company’s provision for income taxes consists of federal, state, local, and foreign taxes in amounts necessary to align the Company’s year-to-date provision for income taxes with the effective tax rate that the Company expects to achieve for the full year. Each quarter, the Company updates its estimate of the annual effective tax rate and records cumulative adjustments as deemed necessary. The income tax provisions for the six months ended June 30, 2017 reflect an estimated global annual effective tax rate of approximately -3.96% from continuing operations. Discontinued operations for the six months ended June 30, 2017 reflect an annual effective tax rate of 0.58%.

As of June 30, 2017, deferred tax assets generated from the Company’s U.S. activities were offset by a valuation allowance because realization depends on generating future taxable income, which, in the Company’s estimation, is not more likely than not to be generated before such net operating loss carryforwards expire. The Company expects its effective tax rate for its current fiscal year to be significantly lower than the statutory rate as a result of a full valuation allowance; therefore, any loss before income taxes does not generate a corresponding income tax benefit.

Income tax expense for the six months ended June 30, 2017 of approximately $227 was attributable primarily to tax deductions related to goodwill, for which there is no corresponding financial statement amortization expense, partially offset by the reduction in the valuation allowance needed following the acquisition of Excalibur's deferred tax liability. The final annual tax rate cannot be determined until the end of the fiscal year; therefore, the actual tax rate could differ from current estimates. Although the Company has an immaterial amount of uncertain tax positions, the Company does not expect to record any additional material provisions for unrecognized tax benefits with the next year.

Related Parties Transactions

6 Months Ended

Jun. 30, 2017

Related Party Transactions Disclosure

Note 9. Related Parties Transactions

On April 22, 2015, XpresSpa entered into a credit agreement and secured promissory note (the “Debt”) with Rockmore Investment Master Fund Ltd. (“Rockmore”) that was amended on August 8, 2016. Rockmore is an investment entity controlled by the Company’s board member, Bruce T. Bernstein. The Debt had an outstanding balance of $6,500 as of both June 30, 2017 and December 31, 2016, which is included in long-term liabilities in the condensed consolidated balance sheets. During the six-month period ended June 30, 2017, XpresSpa paid $430 of interest and recorded $365 of interest expense. During May 2017, per the original agreement and with Rockmore’s consent, the Company elected to extend the maturity date of the Debt from May 1, 2018 to May 1, 2019. No other material terms of the Debt were modified.

In addition, the Company paid $212 to Mr. Bernstein in March 2017 for the legal costs incurred in conjunction with the acquisition of XpresSpa and certain legal proceedings related to litigation with Amiral Holdings SAS (“Amiral”) prior to the completion of such acquisition, as Mr. Bernstein was indemnified by XpresSpa and was a defendant in the Amiral legal proceedings. These costs are included in accounts payable, accrued expenses and other current liabilities in the condensed consolidated balance sheet as of December 31, 2016.

Discontinued Operations and Assets and Liabilities Held For Disposal

6 Months Ended

Jun. 30, 2017

Discontinued Operations and Disposal Groups [Abstract]

Discontinued Operations and Assets and Liabilities Held For Disposal

Note 10. Discontinued Operations and Assets and Liabilities Held For Disposal

During June 2017, the Company concluded that the requirement to report the results of FLI Charge, a wholly-owned subsidiary included in its technology operating segment, as discontinued operations was triggered. The Company is currently negotiating the terms of an agreement to sell FLI Charge to a third-party investor in exchange for a minority investment in the form of shares of preferred stock in the newly created entity, which will own and operate FLI Charge. The Company will not be providing any continued management or financing support to FLI Charge. The transaction is expected to close in the third quarter of 2017. In connection with this agreement, a non-cash impairment loss of $1,092 relating to FLI Charge’s technology assets and goodwill was recorded as of June 30, 2017. The following table represents the components of operating results from discontinued operations, as presented in the condensed consolidated statements of operations and comprehensive loss:

	Three months ended June 30,				Six months ended June 30,
	2017		2016		2017		2016
Revenue	$	19		13		53	$	29
Cost of sales		(36)		—		(68)		(2)
Depreciation, amortization and impairment		(1,130)		(21)		(1,168)		(42)
General and administrative		(405)		(990)		(930)		(1,763)
Loss from discontinued operations before income taxes		(1,552)		(998)		(2,113)		(1,778)
Income tax expense		—		—		—		—
Net loss from discontinued operations	$	(1,552)	$	(998)	$	(2,113)	$	(1,778)

In addition, the following table presents the carrying amounts of the major classes of assets and liabilities held for sale as of June 30, 2017 and December 31, 2016, as presented in the condensed consolidated balance sheets.

	June 30, 2017		December 31, 2016
Accounts receivable, net	$	39	$	45
Inventory		208		53
Other current assets		24		92
Property and equipment, net		196		183
Intangible assets, net		—		377
Goodwill		—		757
Assets held for disposal	$	467	$	1,507

Accounts payable, accrued expenses and other current liabilities	$	88	$	196
Deferred revenue		9		10
Liabilities held for disposal	$	97	$	206

Commitments and Contingencies

6 Months Ended

Jun. 30, 2017

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Note 11. Commitments and Contingencies

Litigation and legal proceedings

Certain of the Company’s outstanding legal matters include speculative claims for substantial or indeterminate amounts of damages. The Company regularly evaluates developments in its legal matters that could affect the amount of any potential liability and makes adjustments as appropriate. Significant judgment is required to determine both the likelihood of there being a liability and the estimated amount of a loss related to such matters.

With respect to the Company’s outstanding legal matters, based on its current knowledge, the Company’s management believes that the amount or range of a potential loss will not, either individually or in the aggregate, have a material adverse effect on its business, consolidated financial position, results of operations or cash flows. However, the outcome of such legal matters is inherently unpredictable and subject to significant uncertainties. The Company evaluated the matters described below, and assessed the probability and likelihood of the occurrence of liability. Based on management’s estimates, the Company recorded $650, which is included in accounts payable, accrued expenses, and other current liabilities in the condensed consolidated balance sheet as of June 30, 2017.

The Company expenses legal fees in the period in which they are incurred.

Cordial

Effective October 2014, XpresSpa terminated its former Airport Concession Disadvantaged Business Enterprise (“ACDBE”) partner, Cordial Endeavor Concessions of Atlanta, LLC (“Cordial”), in several store locations at Hartsfield-Jackson Atlanta International Airport.

On January 3, 2017, XpresSpa filed a lawsuit in the Supreme Court of the State of New York, County of New York against Cordial and several related parties. The lawsuit alleges breach of contract, unjust enrichment, breach of fiduciary duty, fraudulent inducement, fraudulent concealment, tortious interference, and breach of good faith and fair dealing related to XpresSpa’s former partnership with Cordial as XpresSpa’s ACDBE partner in several store locations at Hartsfield-Jackson Atlanta International Airport (the “Cordial Litigation”). On March 3, 2017, XpresSpa filed a first amended complaint against Cordial. On April 5, 2017, Cordial filed a motion to dismiss the Cordial Litigation.

On January 4, 2017, XpresSpa filed a lawsuit in the United States District Court for the Southern District of New York against its former attorney, Kevin Ross, and his law firm, alleging malpractice, unjust enrichment, breach of fiduciary duty, fraudulent inducement, fraudulent concealment, tortious interference, and promissory estoppel related to XpresSpa’s former partnership with Cordial, as well as XpresSpa’s engagement of Kevin Ross as its attorney (the “Ross Litigation”). On March 17, 2017, XpresSpa filed a First Amended Complaint against the defendants. On June 2, 2017, the Ross Defendants filed their answer.

Both the Cordial Litigation and Ross Litigation are pending before the respective courts.

In re Chen et al.

On March 16, 2015, four former employees of XpresSpa who worked at locations in John F. Kennedy International Airport and LaGuardia Airport filed a putative class and collective action wage-hour litigation in the United States District Court for the Eastern District of New York, claiming that they and other spa technicians were misclassified, and that overtime was unpaid. On September 23, 2016, the Court conditionally certified the class. The parties held a mediation on February 28, 2017 and reached an agreement on a settlement in principle. The parties are in the process of finalizing a formal settlement agreement, and preparing a motion to the Court for preliminary approval of a classwide settlement.

Other

XpresSpa is involved in various other claims and legal actions that arise in the ordinary course of business. The Company does not believe that the ultimate resolution of these actions will have a material adverse effect on XpresSpa’s financial position, results of operations, liquidity, or capital resources. However, a significant increase in the number of these claims, or one or more successful claims under which the Company incurs greater liabilities than the Company currently anticipates, could materially and adversely affect the Company’s business, financial condition, results of operations and cash flows.

The Company’s intellectual property operating segment is engaged in litigation, for which no liability is recorded, as the Company does not expect a material negative outcome.

Subsequent Events

6 Months Ended

Jun. 30, 2017

Subsequent Events [Abstract]

Subsequent Events

Note 12. Subsequent Events

On July 26, 2017, the Company entered into an underwriting agreement (the “Underwriting Agreement”) with Roth Capital Partners, LLC, acting as the representative of the several underwriters named therein (collectively, the “Underwriters”), relating to the issuance and sale (the “Offering”) of 6,900,000 shares of the Company’s common stock, par value $0.01 per share (“FORM Common Stock”) including 900,000 shares subject to the Underwriters’ over-allotment option, which was exercised on August 2, 2017 and closed on August 4, 2017. The price to the public in the Offering was $1.10 per share and the Underwriters agreed to purchase the shares of FORM Common Stock from the Company pursuant to the Underwriting Agreement at a purchase price of $1.023 per share. The net proceeds to the Company from the Offering were approximately $6,700 after deducting underwriting discounts and commissions and other estimated offering expenses.

Accounting and Reporting Policies (Policies)

6 Months Ended

Jun. 30, 2017

Accounting Policies [Abstract]

Basis of presentation and principles of consolidation

(a) Basis of presentation and principles of consolidation

Use of estimates

(b) Use of estimates

Revenue recognition

(c) Revenue recognition

Freight billed to customers is recognized as net product revenue and the related freight costs as a cost of sales.

•

whether the risks of ownership have passed to the customer;

•

the customer must have made a fixed commitment to purchase the goods;

•

the customer must request and have a substantial business purpose for ordering on a bill and hold basis;

•

there must be a fixed schedule for delivery that is reasonable and consistent with the customer’s business purpose;

•

the Company cannot retain any specific performance obligations that would make the earnings process incomplete;

•

the goods must be segregated from remaining inventory (i.e., they cannot be used to fill orders for others); and

•

the goods must be complete and ready for shipment.

Cost of Sales

(d) Cost of sales

Cost of sales for the Company’s wellness operating segment consists of store-level costs. Store-level costs include all costs that are directly attributable to the store operations and include:

•

payroll and related benefits for store operations and store-level management;

•

rent, percentage rent and occupancy costs;

•

the cost of merchandise;

•

freight, shipping and handling costs;

•

production costs;

•

inventory shortage and valuation adjustments, including purchase price allocation increase in fair values which was recorded as part of acquisition; and

•

costs associated with sourcing operations.

Cost of sales for the Company’s technology operating segment includes costs to acquire or manufacture goods for inventory.

Recently adopted accounting pronouncements

(e) Recently adopted accounting pronouncements

ASU No. 2017-01, Business Combinations (Topic 805): Clarifying the Definition of a Business

Recent issued accounting pronouncements not yet adopted

(f) Recent issued accounting pronouncements not yet adopted

ASU No. 2017-04, Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment

ASU No. 2017-09, Stock Compensation (Topic 718): Scope of Modification Accounting

Reclassification

(g) Reclassification

Net Loss per Share of Common Stock (Tables)

6 Months Ended

Jun. 30, 2017

Earnings Per Share, Basic and Diluted [Abstract]

Computation of Net Loss per Common Share

The table below presents the computation of basic and diluted net loss per share of common stock:

	Three months ended June 30,				Six months ended June 30,
	2017		2016		2017		2016
Basic numerator:
Net loss from continuing operations attributable to shares of common stock	$	(5,458)	$	(9,809)	$	(11,322)	$	(12,984)
Net loss from discontinued operations attributable to shares of common stock		(1,552)		(998)		(2,113)		(1,778)
Net loss attributable to shares of common stock	$	(7,010)	$	(10,807)	$	(13,435)	$	(14,762)
Basic denominator:
Basic shares of common stock outstanding		19,310,994		14,993,686		19,178,769		14,576,183
Basic loss per share of common stock from continuing operations	$	(0.28)	$	(0.65)	$	(0.59)	$	(0.89)
Basic loss per share of common stock from discontinued operations		(0.08)		(0.07)		(0.11)		(0.12)
Basic net loss per share of common stock	$	(0.36)	$	(0.72)	$	(0.70)	$	(1.01)

Diluted numerator:
Net loss from continuing operations attributable to shares of common stock	$	(5,458)	$	(9,809)	$	(11,322)	$	(12,984)
Net loss from discontinued operations attributable to shares of common stock		(1,552)		(998)		(2,113)		(1,778)
Net loss attributable to shares of common stock	$	(7,010)	$	(10,807)	$	(13,435)	$	(14,762)
Diluted denominator:
Diluted shares of common stock outstanding		19,310,994		14,993,686		19,178,769		14,576,183
Diluted loss per share of common stock from continuing operations	$	(0.28)	$	(0.65)	$	(0.59)	$	(0.89)
Diluted loss per share of common stock from discontinued operations		(0.08)		(0.07)		(0.11)		(0.12)
Diluted net loss per share of common stock	$	(0.36)	$	(0.72)	$	(0.70)	$	(1.01)

Net loss per share data presented excludes from the calculation of diluted net loss the following potentially dilutive securities, as they had an anti-dilutive impact:
Both vested and unvested options to purchase an equal number of shares of common stock of the Company		5,135,399		1,492,434		5,135,399		1,492,434
Unvested restricted stock units (“RSUs”) to issue an equal number of shares of common stock of the Company		400,942		7,808		400,942		7,808
Warrants to purchase an equal number of shares of common stock of the Company		3,430,877		1,006,679		3,430,877		1,006,679
Preferred stock on an as converted basis		3,439,587		—		3,620,626		—
Conversion feature of senior secured notes		—		—		—		159,462
Total number of potentially dilutive instruments, excluded from the calculation of net loss per share		12,406,805		2,506,921		12,587,844		2,666,383

Business Combinations (Tables)

6 Months Ended

Jun. 30, 2017

Business Combinations [Abstract]

Components of Recognized Identified Assets Acquired and Liabilities Assumed

The excess of the purchase price over the net tangible assets and intangible assets was recorded as goodwill. The table below presents preliminary allocation of the purchase price:

	Fair Value
Assets
Current assets (including cash of $26)	$	628
Deferred tax assets		29
Property and equipment		21
Intangible assets		556
Goodwill		2,320
Total assets		3,554

Liabilities
Accounts payable and accrued expenses		1,214
Deferred tax liabilities		215
Total liabilities		1,429
Net assets, fair value	$	2,125

Segment Information (Tables)

6 Months Ended

Jun. 30, 2017

Segment Reporting [Abstract]

Schedule of Segment Reporting Information

	Three months ended June 30,				Six months ended June 30,
	2017		2016		2017		2016
Revenue
Wellness	$	12,927	$	—	$	23,911	$	—
Technology		3,450		2,450		6,941		3,727
Intellectual property		—		8,900		100		9,650
Total revenue		16,377		11,350		30,952		13,377

Cost of sales
Wellness		10,401		—		19,236		—
Technology		2,690		2,180		5,618		3,304
Intellectual property		118		4,243		217		4,963
Total cost of sales		13,209		6,423		25,071		8,267

Segment operating loss
Wellness		(1,992)		—		(4,363)		—
Technology		(742)		(327)		(1,656)		(648)
Intellectual property		(126)		(7,577)		(131)		(8,280)
Corporate		(2,270)		(1,814)		(4,463)		(3,616)
Total segment operating loss		(5,130)		(9,718)		(10,613)		(12,544)
Corporate non-operating expense, net		(228)		(91)		(306)		(440)
Loss from continuing operations before income taxes	$	(5,358)	$	(9,809)	$	(10,919)	$	(12,984)

	June 30, 2017		December 31, 2016
Assets
Wellness	$	53,137	$	57,527
Technology		4,602		8,634
Intellectual property		825		940
Corporate		13,818		15,706
Total assets	$	72,382	$	82,807

Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area

	Three months ended June 30,				Six months ended June 30,
	2017		2016		2017		2016
Revenue
United States	$	15,115	$	11,350	$	28,574	$	13,377
All other countries		1,262		—		2,378		—
Total revenue		16,377		11,350		30,952		13,377

Cost of sales
United States		12,384		6,423		23,569		8,267
All other countries		825		—		1,502		—
Total cost of sales		13,209		6,423		25,071		8,267

Segment operating income (loss)
United States		(5,636)		(9,713)		(11,309)		(12,541)
All other countries		506		(5)		696		(3)
Total segment operating income (loss)		(5,130)		(9,718)		(10,613)		(12,544)
Corporate non-operating expense, net		(228)		(91)		(306)		(440)
Loss from continuing operations before income taxes	$	(5,358)	$	(9,809)	$	(10,919)	$	(12,984)

	June 30, 2017		December 31, 2016
Assets
United States	$	70,380	$	80,053
All other countries		2,002		2,754
Total assets	$	72,382	$	82,807

Fair Value Measurements (Tables)

6 Months Ended

Jun. 30, 2017

Fair Value Disclosures [Abstract]

Assets and Liabilities Measured at Fair Value on Recurring Basis

The following table presents the placement in the fair value hierarchy of derivate warrant liabilities measured at fair value on a recurring basis as of June 30, 2017 and December 31, 2016:

			Fair value measurement at reporting date using
			Quoted prices in
			active markets		Significant other		Significant
			for identical		observable		unobservable
	Balance		assets (Level 1)		inputs (Level 2)		inputs (Level 3)
June 30, 2017:
May 2015 Warrants	$	100	$	—	$	—	$	100

December 31, 2016:
May 2015 Warrants	$	259	$	—	$	—	$	259

Changes in Liabilities Measured at Fair Value Using Significant Unobservable Inputs

	May 2015
	Warrants
December 31, 2016	$	259
Decrease in fair value of the derivative warrant liabilities		(159)
June 30, 2017	$	100

Fair Value Measurements Based Upon Sensitivity and Nature of Inputs

The fair value measurements are evaluated by management to ensure that changes are consistent with expectations of management based upon the sensitivity and nature of the inputs.

June 30, 2017:

Description	Valuation technique	Unobservable inputs	Range
May 2015 Warrants	Black-Scholes-Merton	Volatility		42.12	%
		Risk free interest rate		1.51	%
		Expected term, in years		2.84
		Dividend yield		0.00	%

December 31, 2016:

Description	Valuation technique	Unobservable inputs	Range
May 2015 Warrants	Black-Scholes-Merton	Volatility		45.15	%
		Risk-free interest rate		1.57	%
		Expected term, in years		3.34
		Dividend yield		0.00	%

Assets and Liabilities Measured at Fair Value on Nonrecurring Basis

			Fair value measurement at reporting date using
			Quoted prices in
			active markets		Significant other		Significant
			for identical		observable		unobservable
	Balance		assets (Level 1)		inputs (Level 2)		inputs (Level 3)
June 30, 2017:
Contingent consideration	$	316	$	—	$	—	$	316
FORM Preferred Stock	$	908	$	—	$	—	$	908

Preferred Stock, the Monte-carlo Simulation Variables

To estimate the fair value of the decrease in shares of FORM Preferred Stock, the Monte-Carlo simulation was performed using the following variables:

Description	Valuation technique	Variables	Range
FORM Preferred Stock	Monte-Carlo	Share price as of the Valuation Date	$	1.95
		Volatility		46.0	%
		Risk free interest rate		2.22	%

Stock-based Compensation (Tables)

6 Months Ended

Jun. 30, 2017

Stock Options and Restricted Stock Units Activity

The activity related to stock options and RSUs during the six-month period ended June 30, 2017 consisted of the following:

	RSUs				Options
			Weighted				Weighted				Weighted
			average				average				average
	No. of		grant date		No. of		exercise		Exercise		grant date
	RSUs		fair value		options		price		price range		fair value
Outstanding as of January 1, 2017		—		—		3,679,101	$	7.60	$	1.55 – 55.00	$	5.41
Granted		400,942	$	2.12		1,545,000	$	2.12	$	2.12 – 2.15	$	0.93
Vested/Exercised		—		—		—		—		—		—
Forfeited		—		—		(72,334)	$	24.80	$	1.55 – 37.20	$	16.81
Expired		—		—		(16,368)	$	43.66	$	9.94 – 55.00	$	22.02
Outstanding as of June 30, 2017		400,942	$	2.12		5,135,399	$	5.60	$	1.55 – 41.00	$	3.85
Exercisable as of June 30, 2017		—				2,459,982	$	9.72	$	1.55 – 41.00

Directors and Employees [Member]

Schedule of Options Granted

The following table illustrates the options granted during the six-month period ended June 30, 2017.

Assumptions used in

Black-

No. of

Exercise

Fair value at

Scholes option pricing

Title

Grant date

options

price

grant date

Vesting terms

model

Directors, management, and

January 2017

1,545,000

$2.12 – $2.15

$0.89 – $0.96

Over 1 year for directors; Over 3 years

Volatility: 44.27% – 44.90%

employees

for management and employees

Risk free interest rate: 1.95% – 2.16%

Expected term, in years: 5.29 – 5.79

Dividend yield: 0.00%

Management and Employees [Member]

Schedule of Options Granted

The following table illustrates the RSUs granted during the six-month period June 30, 2017.

Title

Grant date

No. of RSUs

Fair value at grant date

Vesting term

Management and employees

January 2017

400,942

2.12

Over 1 year period, vesting on 1 year anniversary of grant date

Discontinued Operations and Assets and Liabilities Held For Disposal (Tables)

6 Months Ended

Jun. 30, 2017

Discontinued Operations and Disposal Groups [Abstract]

Disposal Groups, Including Discontinued Operations [Table Text Block]

The following table represents the components of operating results from discontinued operations, as presented in the condensed consolidated statements of operations and comprehensive loss:

	Three months ended June 30,				Six months ended June 30,
	2017		2016		2017		2016
Revenue	$	19		13		53	$	29
Cost of sales		(36)		—		(68)		(2)
Depreciation, amortization and impairment		(1,130)		(21)		(1,168)		(42)
General and administrative		(405)		(990)		(930)		(1,763)
Loss from discontinued operations before income taxes		(1,552)		(998)		(2,113)		(1,778)
Income tax expense		—		—		—		—
Net loss from discontinued operations	$	(1,552)	$	(998)	$	(2,113)	$	(1,778)

	June 30, 2017		December 31, 2016
Accounts receivable, net	$	39	$	45
Inventory		208		53
Other current assets		24		92
Property and equipment, net		196		183
Intangible assets, net		—		377
Goodwill		—		757
Assets held for disposal	$	467	$	1,507

Accounts payable, accrued expenses and other current liabilities	$	88	$	196
Deferred revenue		9		10
Liabilities held for disposal	$	97	$	206

- Definition

Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=65878427&loc=SL51721533-107759

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 4B
-URI http://asc.fasb.org/extlink&oid=64827811&loc=SL51721665-107760

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=64827811&loc=d3e1474-107760

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=64827811&loc=d3e1361-107760

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=64827811&loc=SL51721683-107760

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 3A
-URI http://asc.fasb.org/extlink&oid=84176398&loc=SL51724579-110230

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5C
-URI http://asc.fasb.org/extlink&oid=64827811&loc=SL51721675-107760

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 4A
-URI http://asc.fasb.org/extlink&oid=64827811&loc=SL51721663-107760

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84176398&loc=d3e2941-110230

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5B
-URI http://asc.fasb.org/extlink&oid=64827811&loc=SL51721673-107760

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 3A
-URI http://asc.fasb.org/extlink&oid=64827811&loc=SL51721659-107760

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5A
-URI http://asc.fasb.org/extlink&oid=64827811&loc=SL51721671-107760

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5D
-URI http://asc.fasb.org/extlink&oid=64827811&loc=SL51721677-107760

+ Details

General (Additional Information) (Details) - Infomedia [Member]	Jun. 30, 2017
Maximum [Member]
Cost Method Investment Ownership Percentage	11.00%
Minimum [Member]
Cost Method Investment Ownership Percentage	8.25%

Net Loss per Share of Common Stock (Computation of basic and diluted net losses per common share) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Earnings Per Share Disclosure [Line Items]
Net loss attributable to shares of common stock	$ (7,010)	$ (10,807)	$ (13,435)	$ (14,762)
Basic shares of common stock outstanding	19,310,994	14,993,686	19,178,769	14,576,183
Diluted shares of common stock outstanding	19,310,994	14,993,686	19,178,769	14,576,183
Net loss per share data presented excludes from the calculation of diluted net loss the following potentially dilutive securities, as they had an anti-dilutive impact:
Total number of potentially dilutive instruments, excluded from the calculation of net loss per share	12,406,805	2,506,921	12,587,844	2,666,383
Basic numerator [Member]
Earnings Per Share Disclosure [Line Items]
Net loss from continuing operations attributable to shares of common stock	$ (5,458)	$ (9,809)	$ (11,322)	$ (12,984)
Net loss from discontinued operations attributable to shares of common stock	(1,552)	(998)	(2,113)	(1,778)
Net loss attributable to shares of common stock	$ (7,010)	$ (10,807)	$ (13,435)	$ (14,762)
Basic denominator [Member]
Earnings Per Share Disclosure [Line Items]
Basic shares of common stock outstanding	19,310,994	14,993,686	19,178,769	14,576,183
Basic loss per share of common stock from continuing operations	$ (0.28)	$ (0.65)	$ (0.59)	$ (0.89)
Basic loss per share of common stock from discontinued operations	(0.08)	(0.07)	(0.11)	(0.12)
Basic net loss per share of common stock	$ (0.36)	$ (0.72)	$ (0.70)	$ (1.01)
Diluted numerator [Member]
Earnings Per Share Disclosure [Line Items]
Net loss from continuing operations attributable to shares of common stock	$ (5,458)	$ (9,809)	$ (11,322)	$ (12,984)
Net loss from discontinued operations attributable to shares of common stock	(1,552)	(998)	(2,113)	(1,778)
Net loss attributable to shares of common stock	$ (7,010)	$ (10,807)	$ (13,435)	$ (14,762)
Diluted denominator [Member]
Earnings Per Share Disclosure [Line Items]
Diluted shares of common stock outstanding	19,310,994	14,993,686	19,178,769	14,576,183
Diluted loss per share of common stock from continuing operations	$ (0.28)	$ (0.65)	$ (0.59)	$ (0.89)
Diluted loss per share of common stock from discontinued operations	(0.08)	(0.07)	(0.11)	(0.12)
Diluted net loss per share of common stock	$ (0.36)	$ (0.72)	$ (0.70)	$ (1.01)
Vested and unvested options to purchase an equal number of shares of common stock of the Company [Member]
Net loss per share data presented excludes from the calculation of diluted net loss the following potentially dilutive securities, as they had an anti-dilutive impact:
Total number of potentially dilutive instruments, excluded from the calculation of net loss per share	5,135,399	1,492,434	5,135,399	1,492,434
Unvested Restricted Stock Units ("RSU") [Member]
Net loss per share data presented excludes from the calculation of diluted net loss the following potentially dilutive securities, as they had an anti-dilutive impact:
Total number of potentially dilutive instruments, excluded from the calculation of net loss per share	400,942	7,808	400,942	7,808
Warrants to purchase an equal number of shares of common stock of the Company [Member]
Net loss per share data presented excludes from the calculation of diluted net loss the following potentially dilutive securities, as they had an anti-dilutive impact:
Total number of potentially dilutive instruments, excluded from the calculation of net loss per share	3,430,877	1,006,679	3,430,877	1,006,679
Conversion feature of Senior Secured Notes [Member]
Net loss per share data presented excludes from the calculation of diluted net loss the following potentially dilutive securities, as they had an anti-dilutive impact:
Total number of potentially dilutive instruments, excluded from the calculation of net loss per share	0	0	0	159,462
Convertible Perferred Stock [Member]
Net loss per share data presented excludes from the calculation of diluted net loss the following potentially dilutive securities, as they had an anti-dilutive impact:
Total number of potentially dilutive instruments, excluded from the calculation of net loss per share	3,439,587	0	3,620,626	0

Business Combinations (Additional Information) (Details) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended	6 Months Ended
	Feb. 02, 2017	Jun. 30, 2017	Jun. 30, 2017	Jul. 26, 2017	Dec. 31, 2016
Business Combination [Line Items]
Common Stock, Par Or Stated Value Per Share	$ 0.01	$ 0.01	$ 0.01		$ 0.01
Business Combination, Consideration Transferred	$ 2,125
Stock Issued During Period, Shares, Acquisitions	888,573
Business Combination, Consideration Transferred, Liabilities Incurred	$ 316
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable	$ 1,809
Business Combination, Control Obtained Description	to the former stockholders of Excalibur (the “Excalibur Sellers”). In addition, the Excalibur Sellers will, in the three years following the closing of this transaction, also receive $500 for each $2,000 of gross profit generated by a specified list of Excalibur accounts annually, until such cumulative gross profit reaches $6,000, and an additional $500 when such cumulative profit reaches $10,000, such amounts are payable in either cash or the Company’s common stock, at the election of the Company.
Adjustments to Additional Paid in Capital, Increase in Carrying Amount of Redeemable Preferred Stock			$ 908
Subsequent Event [Member]
Business Combination [Line Items]
Shares Issued, Price Per Share				$ 1.10
Subsequent Event [Member] \| Over-Allotment Option [Member]
Business Combination [Line Items]
Shares Issued, Price Per Share				$ 1.023
Common Stock [Member]
Business Combination [Line Items]
Adjustments to Additional Paid in Capital, Increase in Carrying Amount of Redeemable Preferred Stock			$ 0
Common Stock [Member] \| XpresSpa Holdings LLC [Member]
Business Combination [Line Items]
Conversion of Stock, Shares Issued			362,077
FORM Preferred Stock [Member] \| XpresSpa Holdings LLC [Member]
Business Combination [Line Items]
Common Stock, Par Or Stated Value Per Share		$ 0.01	$ 0.01
Preferred Stock, Liquidation Preference, Value		$ 20,638	$ 20,638		$ 23,588
Preferred Stock, Shares Outstanding		429,948	429,948		491,427
Conversion of Stock, Shares Converted		45,260
Preferred Stock Shares Reduction			16,219

Business Combinations (Purchase Price The Net Tangible assets And Intangible Assets Allocation) (Details) - USD ($) $ in Thousands	Jun. 30, 2017	Dec. 31, 2016
Assets
Goodwill	$ 25,821	$ 24,409
Excalibur [Member]
Assets
Current assets (including cash of $26)	628
Deferred tax assets	29
Property and equipment	21
Intangible assets	556
Goodwill	2,320
Total assets	3,554
Liabilities
Accounts payable and accrued expenses	1,214
Deferred tax liabilities	215
Total liabilities	1,429
Net assets, fair value	$ 2,125

Segment Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
Segment Information (Details) - USD ($) $ in Thousands	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016	Dec. 31, 2016
Revenue:
Total revenue	$ 16,377	$ 11,350	$ 30,952	$ 13,377
Cost of sales
Total cost of sales	13,209	6,423	25,071	8,267
Segment operating loss:
Total segment operating loss	(5,130)	(9,718)	(10,613)	(12,544)
Corporate non-operating expense, net	(228)	(91)	(306)	(440)
Loss from continuing operations before income taxes	(5,358)	(9,809)	(10,919)	(12,984)
Assets
Total assets	72,382		72,382		$ 82,807
Corporate [Member]
Segment operating loss:
Total segment operating loss	(2,270)	(1,814)	(4,463)	(3,616)
Assets
Total assets	13,818		13,818		15,706
Intellectual Property [Member]
Revenue:
Total revenue	0	8,900	100	9,650
Cost of sales
Total cost of sales	118	4,243	217	4,963
Segment operating loss:
Total segment operating loss	(126)	(7,577)	(131)	(8,280)
Assets
Total assets	825		825		940
Wellness Service [Member]
Revenue:
Total revenue	12,927	0	23,911	0
Cost of sales
Total cost of sales	10,401	0	19,236	0
Segment operating loss:
Total segment operating loss	(1,992)	0	(4,363)	0
Assets
Total assets	53,137		53,137		57,527
Technology Service [Member]
Revenue:
Total revenue	3,450	2,450	6,941	3,727
Cost of sales
Total cost of sales	2,690	2,180	5,618	3,304
Segment operating loss:
Total segment operating loss	(742)	$ (327)	(1,656)	$ (648)
Assets
Total assets	$ 4,602		$ 4,602		$ 8,634

Segment Information (Geographical Revenue, Segment Operating Loss and Total Asset Information) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016	Dec. 31, 2016
Revenue
Total revenue	$ 16,377	$ 11,350	$ 30,952	$ 13,377
Cost of sales
Total cost of sales	13,209	6,423	25,071	8,267
Segment operating income (loss)
Total segment operating income (loss)	(5,130)	(9,718)	(10,613)	(12,544)
Corporate non-operating expense, net	(228)	(91)	(306)	(440)
Loss from continuing operations before income taxes	(5,358)	(9,809)	(10,919)	(12,984)
Assets
Assets	72,382		72,382		$ 82,807
United States
Revenue
Total revenue	15,115	11,350	28,574	13,377
Cost of sales
Total cost of sales	12,384	6,423	23,569	8,267
Segment operating income (loss)
Total segment operating income (loss)	(5,636)	(9,713)	(11,309)	(12,541)
Assets
Assets	70,380		70,380		80,053
All other countries
Revenue
Total revenue	1,262	0	2,378	0
Cost of sales
Total cost of sales	825	0	1,502	0
Segment operating income (loss)
Total segment operating income (loss)	506	$ (5)	696	$ (3)
Assets
Assets	$ 2,002		$ 2,002		$ 2,754

Fair Value Measurements (Assets and Liabilities Measured at Fair Value on Recurring Basis) (Details) - Warrant [Member] - USD ($) $ in Thousands	Jun. 30, 2017	Dec. 31, 2016
Liabilities
Derivative liabilities	$ 100	$ 259
Fair Value, Inputs, Level 1 [Member]
Liabilities
Derivative liabilities	0	0
Fair Value, Inputs, Level 2 [Member]
Liabilities
Derivative liabilities	0	0
Fair Value Inputs Level 3 [Member]
Liabilities
Derivative liabilities	$ 100	$ 259

Fair Value Measurements (Changes In Company's Liabilities Measured At Fair Value Using Significant Unobservable Inputs) (Details) - May Twenty Fifteen Warrants [Member] $ in Thousands	6 Months Ended
	Jun. 30, 2017 USD ($)
Derivative Liability, December 31, 2016	$ 259
Decrease in fair value of the derivative warrant liabilities	(159)
Derivative Liability, June 30, 2017	$ 100

Fair Value Measurements (Based Upon Sensitivity and Nature of Inputs) (Details) - May 2015 Warrants [Member]	6 Months Ended	12 Months Ended
	Jun. 30, 2017	Dec. 31, 2016
Fair Value Inputs, Liabilities, Quantitative Information [Line Items]
Volatility	42.12%	45.15%
Risk free interest rate	1.51%	1.57%
Expected term, in years	2 years 10 months 2 days	3 years 4 months 2 days
Dividend yield	0.00%	0.00%

Fair Value Measurement (Intangible Assets Measured At Fair Value On A Non-Recurring Basis) (Details) - Fair Value, Measurements, Recurring [Member] $ in Thousands	Jun. 30, 2017 USD ($)
FORM Preferred Stock [Member]
Fair Value, Assets Measured on Recurring and Nonrecurring Basis, Alternative [Abstract]
Liabilities, Fair Value Disclosure, Nonrecurring	$ 908
Contingent consideration [Member]
Fair Value, Assets Measured on Recurring and Nonrecurring Basis, Alternative [Abstract]
Liabilities, Fair Value Disclosure, Recurring	316
Fair Value, Inputs, Level 2 [Member] \| FORM Preferred Stock [Member]
Fair Value, Assets Measured on Recurring and Nonrecurring Basis, Alternative [Abstract]
Liabilities, Fair Value Disclosure, Nonrecurring	0
Fair Value, Inputs, Level 2 [Member] \| Contingent consideration [Member]
Fair Value, Assets Measured on Recurring and Nonrecurring Basis, Alternative [Abstract]
Liabilities, Fair Value Disclosure, Recurring	0
Fair Value Inputs Level 3 [Member] \| FORM Preferred Stock [Member]
Fair Value, Assets Measured on Recurring and Nonrecurring Basis, Alternative [Abstract]
Liabilities, Fair Value Disclosure, Nonrecurring	908
Fair Value Inputs Level 3 [Member] \| Contingent consideration [Member]
Fair Value, Assets Measured on Recurring and Nonrecurring Basis, Alternative [Abstract]
Liabilities, Fair Value Disclosure, Recurring	316
Fair Value, Inputs, Level 1 [Member] \| FORM Preferred Stock [Member]
Fair Value, Assets Measured on Recurring and Nonrecurring Basis, Alternative [Abstract]
Liabilities, Fair Value Disclosure, Nonrecurring	0
Fair Value, Inputs, Level 1 [Member] \| Contingent consideration [Member]
Fair Value, Assets Measured on Recurring and Nonrecurring Basis, Alternative [Abstract]
Liabilities, Fair Value Disclosure, Recurring	$ 0

Fair Value Measurements ( FORM Preferred Stock, the Monte-Carlo simulation variables) (Details) - Fair Value Inputs Level 3 [Member]	6 Months Ended
	Jun. 30, 2017 $ / shares
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair Value Measurements, Valuation Processes, Description	FORM Preferred Stock
Fair Value Measurements, Valuation Techniques	Monte-Carlo
Share price as of the Valuation Date	$ 1.95
Volatility	46.00%
Risk free interest rate	2.22%

Stock-based Compensation (Additional Information) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Stockholders Equity [Line Items]
Share-Based Compensation	$ 732	$ 499	$ 1,473	$ 962
Two Thousand Twelve Stock Option Plan [Member]
Stockholders Equity [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant	1,258,603		1,258,603

Stock-based Compensation (Schedule Of Common Stock Options Granted) (Details) - $ / shares	6 Months Ended
	Jun. 30, 2017	Dec. 31, 2016
Stockholders Equity [Line Items]
Exercise price	$ 5.60	$ 7.6
Fair value at grant date	0.93
Maximum [Member]
Stockholders Equity [Line Items]
Exercise price	41.00	55.00
Minimum [Member]
Stockholders Equity [Line Items]
Exercise price	$ 1.55	$ 1.55
Management Directors and Employees [Member] \| Employee Stock Option [Member]
Stockholders Equity [Line Items]
Grant date	January 2017
No. of RSUs Options	1,545,000
Vesting terms	Over 1 year for directors; Over 3 years for management and employees
Volatility Rate, Minimum	44.27%
Volatility Rate, Maximum	44.90%
Risk free interest rate, Minimum	1.95%
Risk free interest rate, Maximum	2.16%
Dividend yield	0.00%
Management Directors and Employees [Member] \| Maximum [Member] \| Employee Stock Option [Member]
Stockholders Equity [Line Items]
Exercise price	$ 2.15
Fair value at grant date	$ 0.96
Expected term, in years	5 years 9 months 14 days
Management Directors and Employees [Member] \| Minimum [Member] \| Employee Stock Option [Member]
Stockholders Equity [Line Items]
Exercise price	$ 2.12
Fair value at grant date	$ 0.89
Expected term, in years	5 years 3 months 14 days
Management and Employees [Member] \| Restricted Stock Units (RSUs) [Member]
Stockholders Equity [Line Items]
Grant date	January 2017
No. of RSUs Options	400,942
Fair value at grant date	$ 2.12
Vesting terms	Over 1 year period, vesting on 1 year anniversary of grant date

Stock-based Compensation (Stock options and RSU activity) (Details)	6 Months Ended
	Jun. 30, 2017 $ / shares shares
Stockholders Equity [Line Items]
No. of options, Outstanding \| shares	3,679,101
No. of options, Granted \| shares	1,545,000
No. of options, Vested/Exercised \| shares	0
No. of options, Forfeited \| shares	(72,334)
No. of options, Expired \| shares	(16,368)
No. of options, Outstanding \| shares	5,135,399
No. of options, Exercisable \| shares	2,459,982
Exercise price range, Outstanding	$ 7.6
Exercise price range, Granted	2.12
Exercise price range, Vested/Exercised	0
Exercise price range, Forfeited	24.80
Exercise price range, Expired	43.66
Exercise price range, Outstanding	5.60
Exercise price range, Exercisable	9.72
Weighted average grant date fair value, Outstanding	5.41
Weighted average grant date fair value, Granted	0.93
Weighted average grant date fair value, Vested/Exercised	0
Weighted average grant date fair value, Forfeited	16.81
Weighted average grant date fair value, Expired	22.02
Weighted average grant date fair value, Outstanding	$ 3.85
Restricted Stock [Member]
Stockholders Equity [Line Items]
No. of RSUS, Outstanding \| shares	0
No. of RSUs, Granted \| shares	400,942
No. of RSUs, Vested/Exercised \| shares	0
No. of RSUs, Forfeited \| shares	0
No. of RSUs, Expired \| shares	0
No. of RSUS, Outstanding \| shares	400,942
No. of RSUs, Exercisable \| shares	0
Weighted average grant date fair value, Outstanding	$ 0
Weighted average grant date fair value, Granted	2.12
Weighted average grant date fair value, Vested/Exercised	0
Weighted average grant date fair value, Forfeited	0
Weighted average grant date fair value, Expired	0
Weighted average grant date fair value, Outstanding	2.12
Weighted average grant date fair value, Exercisable	0
Minimum [Member]
Stockholders Equity [Line Items]
Exercise price range, Outstanding	1.55
Exercise price range, Granted	2.12
Exercise price range, Forfeited	1.55
Exercise price range, Expired	9.94
Exercise price range, Outstanding	1.55
Exercise price range, Exercisable	1.55
Maximum [Member]
Stockholders Equity [Line Items]
Exercise price range, Outstanding	55.00
Exercise price range, Granted	2.15
Exercise price range, Forfeited	37.20
Exercise price range, Expired	55.00
Exercise price range, Outstanding	41.00
Exercise price range, Exercisable	$ 41.00

Income Taxes (Additional Information) (Details) $ in Thousands	6 Months Ended
	Jun. 30, 2017 USD ($)
Income Taxes [Line Items]
Effective Income Tax Rate Reconciliation, Percent	(3.96%)
Business Acquisition, Goodwill, Expected Tax Deductible Amount	$ 227
Effective Income Tax Rate Discontinued Operations	0.58%

Related Parties Transactions (Additional Information) (Details) - USD ($) $ in Thousands	1 Months Ended	6 Months Ended
	Mar. 31, 2017	Jun. 30, 2017	Dec. 31, 2016
Bruce T. Bernstein [Member]
Payments for Legal Settlements	$ 212
XpresSpa Engagement [Member]
Debt Instrument, Face Amount		$ 6,500	$ 6,500
Payments For Interest Expenses		430
Interest Expense, Debt		$ 365
Debt Instrument, Maturity Date Range, Start		May 01, 2018
Debt Instrument, Maturity Date Range, End		May 01, 2019

Discontinued Operations and Assets and Liabilities Held For Disposal (Additional Information) (Details) $ in Thousands	6 Months Ended
	Jun. 30, 2017 USD ($)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Equity Method Investment, Other than Temporary Impairment	$ 1,092

Discontinued Operations and Assets and Liabilities Held For Disposal (Schedule Of Discontinued Operations, As Presented In Consolidated Statements Of Operations) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Revenue	$ 19	$ 13	$ 53	$ 29
Cost of sales	(36)	0	(68)	(2)
Depreciation, amortization and impairment	(1,130)	(21)	(1,168)	(42)
General and administrative	(405)	(990)	(930)	(1,763)
Loss from discontinued operations before income taxes	(1,552)	(998)	(2,113)	(1,778)
Income tax expense	0	0	0	0
Net loss from discontinued operations	$ (1,552)	$ (998)	$ (2,113)	$ (1,778)

- Definition

Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.

+ References + Details

- Definition

Amount of tax expense (benefit) related to a discontinued operation. Includes, but is not limited to, tax expense (benefit) related to income (loss) from operations during the phase-out period, tax expense (benefit) related to gain (loss) on disposal, tax expense (benefit) related to gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and tax expense (benefit) related to adjustments of a prior period gain (loss) on disposal.

+ References + Details

- Definition

Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.

+ References + Details

Discontinued Operations and Assets and Liabilities Held For Disposal (Carrying Amounts Of the Major Classes Of Assets and Liabilities) (Details) - USD ($) $ in Thousands	Jun. 30, 2017	Dec. 31, 2016
Accounts receivable, net	$ 39	$ 45
Inventory	208	53
Other current assets	24	92
Property and equipment, net	196	183
Intangible assets, net	0	377
Goodwill	0	757
Assets held for disposal	467	1,507
Accounts payable, accrued expenses and other current liabilities	88	196
Deferred revenue	9	10
Liabilities held for disposal	$ 97	$ 206

Commitments and Contingencies (Additional Information) (Details)	Jun. 30, 2017 USD ($)
Accrued Liabilities [Member]
Loss Contingencies [Line Items]
Estimated Litigation Liability, Current	$ 650

Subsequent Events (Additional Information) (Details) - USD ($)	1 Months Ended
	Jul. 26, 2017	Jun. 30, 2017	Dec. 31, 2016
Subsequent Event [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number		5,135,399	3,679,101
Subsequent Event [Member]
Subsequent Event [Line Items]
Stock Issued During Period, Shares, New Issues	6,900,000
Proceeds from Issuance of Common Stock	$ 6,700
Shares Issued, Price Per Share	$ 1.10
Subsequent Event [Member] \| Over-Allotment Option [Member]
Subsequent Event [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	900,000
Shares Issued, Price Per Share	$ 1.023